Table I. Baseline characteristics of the patients with hepatocellular carcinoma enrolled in this study.
HBV: Hepatitis B virus; HCV: hepatitis C virus; NBNC: non-HBV and non-HCV; ECOG-PS: Eastern Cooperative Oncology Group performance status; mALBI: modified albumin–bilirubin; BCLC: Barcelona Cancer Liver Clinic; AFP: alpha fetoprotein.